Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Healthcare
Create a narrative
Tristel Community
AIM:TSTL Community
1
Narratives
written by author
0
Comments
on narratives written by author
16
Fair Values set
on narratives written by author
Create a narrative
Tristel
Popular
Undervalued
Overvalued
Community Investing Ideas
Tristel
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
US Expansion And Direct Sales Will Open New Opportunities
Key Takeaways Geographic expansion, especially into the U.S., is expected to drive significant revenue growth in medical device decontamination. A shift to direct sales and strong OEM partnerships could enhance profitability by capturing more value and increasing product adoption rates.
View narrative
UK£4.45
FV
15.8% undervalued
intrinsic discount
11.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
TSTL
TSTL
Tristel
Your Fair Value
UK£
Current Price
UK£3.75
21.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
72m
2015
2018
2021
2024
2025
2027
2030
Revenue UK£72.0m
Earnings UK£10.1m
Advanced
Set Fair Value